Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Only one reality about shipments of commercial parts remains:
Since the premature and false announcement about shipments of commercial parts when the stock jumped up to 40 cents, we have been steipping in the midst.
It is only by production and shipments of commercial parts that this stock will go over 40 cents.
We are still IN THE MIDST.
Don't be too giddy and don't be a patsy.
Anyone who can bothers to take the time to expand a chart beyond 3 months will put this artificial run-up into proper perspective. This run-up pales in significance to the big run-ups in the history of this stock. And it is easy to see how many run-ups in the past 4 to five years stayed at their peaks, or stayed at their half-points, or even stayed at their quarter points of the run-ups.
Don't you think it's awfully coincidental that BPAX happened to purchase a multi-million dollar gel machine when they had no internal expertise or history in manufacturing... and then ended up merging with a manufacturing company because it was the "best option" for the shareholders?
Catty, in the event Simes and company were not acting in our best interest, in the long run, I would recommend that we keep the posts available to help build a case against them. We have a lot of info but it would be worth pouring over with a fine tooth comb. It could only solidify a lawsuit's claims and/or criminal proceedings should it come to that.
The question you have to ask yourself: is the combined company (combined assets, products, pipeline, cash and potential), worth more or less than $70 million?
Lurazh, I have to agree, in light of the financial crisis we are just coming out of, yet Europe is still mired in. Now is not the time to be worrying about margins being called, unless covering is a non issue for you. There is just too much global instability.
Catty, what I think Joshuri was saying was that we may slip below $5, so he was just concerned that you may get a margin call. Knowing bpax, I would never touch margin money....
The only partners listed on ANI website are Teva and Aduro.
Begs to question what about Elestrin and Meda agreeement.
In fairness Pryzbyl has stated in the past he brings to light immediate revenue generators only, focusing in the present Elestrin milestone payments may be too far off for him to include in the filing.
On the other hand you have to wonder, is the women's division being sold?
ANI is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. In two facilities with combined manufacturing, packaging and laboratory capacity totaling 173,000 square feet, ANI manufactures oral solid dose products, as well as liquids and topicals, including narcotics and those that must be manufactured in a fully contained environment due to their potency and/or toxicity. ANI also performs contract manufacturing for other pharmaceutical companies. Over the last two years ANI has launched three new products and has eleven products in development. ANI’s targeted areas of product development include narcotics, anti-cancers and hormones (potent compounds), and extended release niche generic product opportunities. ANI’s other products include an FDA-approved testosterone gel, which is licensed to Teva Pharmaceuticals USA. For more information please visit our website www.anipharmaceuticals.com.
They know we have been watching and researching their moves and continue to do so. This will persist until the trust in the new management has been reestablished (still a long way to go). In the meantime I continue to build a case I hope, we will never have to use.
Josh: I think you misread my post. I didn't say I would add more BPAX - I said I put my margin money into other situtions. Anyway, I appreciate your concern.
Would the next logical step be to create upward momentum be by getting some analysts to initiate coverage and set new target prices based on Q-2 results before making any additional announcements?
I know, logic and Biosante in the same sentence is hard to imagine. But we are ANI now.
catty HAPPY BELATED BIRTHDAY. lol here in Honolulu I'm 6 hrs behind Ohio time and somewhere along the line I lost s day. hope you had a great time. jump on over to the island and I'll buy you a drink. lol.
that's the reverse split figure that ANIP did with their stock i think? What im wondering is how many bpax shares yesterday, are worth in ANIP shares today?
Sweet god catty, don't even think of doing it. You've been taken to the cleaners by BPAX. I strongly urge against it. I would want you to tell me the same. If I get all delusional on here someone please slap me.
this is criminal and security fraud in front of open eyes and no one, no one is doing anything about this???????????????? Simes should rot in jail and the BOD should be fired for their lies to shareholders. I hope their a$$es get sued by someone....
There's a bright side to this r/s...it released a lot a buying power for me since it's marginable. Not that I'm adding to it, but I was able to to buy another stock.
I think we should get information in July about the hormone compounding and dilutions being banned by FDA. Then we inherit a monopoly on test for women w/ libigel.
Ahahahaha. Post of the day right there. What is the OS and AS exactly now? If there is any wiggle room whatsoever in-between the two, I guarantee they do a sell off. The only way I'm convinced there will be no selling is if the AS matches the OS.
With less than 10 million OS and the female component of libigel being a 2 billion per year market, some math will tell you that 200 / share / year is possible. Especially when the word gets out that the benefits of test for women are as profound as men.
News 
Market Data 
Discover 
AI
